Cardiovascular implications in the treatment of obstructive sleep apnea.
about
Is insulin the new intermittent hypoxia?Prevalence and clinical significance of supine-dependent obstructive sleep apnea in patients using oral appliance therapy.Obstructive sleep apnoea as a risk factor for atherosclerosis - implication for preventive and personalised treatment.Treatment of obstructive sleep apnea using a custom-made titratable duobloc oral appliance: a prospective clinical studyThe Use of Remotely Controlled Mandibular Positioner as a Predictive Screening Tool for Mandibular Advancement Device Therapy in Patients with Obstructive Sleep Apnea through Single-Night Progressive Titration of the Mandible: A Systematic Review.Relationship between obstructive sleep apnea severity index and left ventricular function and volume.Central and peripheral factors contributing to obstructive sleep apneas.Retention of mandibular advancement devices in the treatment of obstructive sleep apnea: an in vitro pilot study.Sleep medicine care under one roof: a proposed model for integrating dentistry and medicine.Perspectives on the reduction in cardiovascular mortality with oral appliance therapy for patients with severe obstructive sleep apnoea intolerant to continuous positive airway pressure.Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system.The predictive value of drug-induced sleep endoscopy for CPAP titration in OSA patients.Serum ferritin and obstructive sleep apnea-epidemiological study.The long-term effects of mandibular advancement splint on cardiovascular fitness and psychomotor performance in patients with mild to moderate obstructive sleep apnea: a prospective study.Evaluation of the impact of a clinical pathway on the organization of a multidisciplinary dental sleep clinic.Implanted upper airway stimulation device for obstructive sleep apnea.
P2860
Q33622116-D08E14C3-234A-4A1E-A0D0-D81373A773CEQ34126173-9E5A4434-3D6E-4D3E-97E2-8212BE80CDFBQ36117866-D3498871-47DE-4EF1-88AA-951B599F561EQ36847546-B396469F-34A4-490E-9A0D-C6DF83303103Q37277004-EEAD9037-F1C1-4F63-A512-055DB6FA838FQ37292301-5F027D5A-B0C2-495C-A8D3-E0D1CFE74149Q37513401-C8F8DD5E-A2AC-4147-8F12-AF326DC60920Q37735164-92E2525C-73F9-47E7-990F-AFFAB988EBACQ38129051-800FC42C-ED66-4CAC-8BFE-D7B2B906F76BQ44328840-1FB8AA30-AF56-4231-A4C1-91792773C3C9Q45330173-D85F9C47-F1BA-44E4-AF96-CD98BA0BFE9FQ47299468-6E13CB11-2BE3-4DBC-8A44-466AE09FD16BQ47311435-B2F3CAA1-2DFB-43DA-8D08-93B4054EC4E1Q47711277-CF0B8755-6D31-4FC9-961C-2C40EC0304ECQ48157402-1403E0E2-DCA1-49CA-8C2C-472A776A7493Q48246599-193EEB5C-E532-4D30-8CD0-E8BF359F46A0
P2860
Cardiovascular implications in the treatment of obstructive sleep apnea.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Cardiovascular implications in the treatment of obstructive sleep apnea.
@en
Cardiovascular implications in the treatment of obstructive sleep apnea.
@nl
type
label
Cardiovascular implications in the treatment of obstructive sleep apnea.
@en
Cardiovascular implications in the treatment of obstructive sleep apnea.
@nl
prefLabel
Cardiovascular implications in the treatment of obstructive sleep apnea.
@en
Cardiovascular implications in the treatment of obstructive sleep apnea.
@nl
P2093
P2860
P1476
Cardiovascular implications in the treatment of obstructive sleep apnea.
@en
P2093
An Boudewyns
Bhavani Kashyap
Johan Verbraecken
Wilfried De Backer
P2860
P2888
P356
10.1007/S12265-010-9238-Y
P407
P577
2010-11-20T00:00:00Z